Summit Tx Capital, L.P. Cytokinetics Inc Call Options Transaction History
Summit Tx Capital, L.P.
- $2.32 Trillion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CYTK
# of Institutions
404Shares Held
126MCall Options Held
3.7MPut Options Held
890K-
Black Rock Inc. New York, NY14.7MShares$438 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$354 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$297 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$238 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$182 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $2.81B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...